Literature DB >> 6399494

Clinical applications of monoclonal antibodies.

K D Maudgil, S K Gupta, B S Narang.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6399494     DOI： 10.1007/BF02776388

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  56 in total

1.  Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation.

Authors:  K A Krolick; J W Uhr; E S Vitetta
Journal:  Nature       Date:  1982-02-18       Impact factor: 49.962

2.  Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen.

Authors:  D M Goldenberg; E E Kim; F H DeLand; S Bennett; F J Primus
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

3.  Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

Authors:  A H Filipovich; P B McGlave; N K Ramsay; G Goldstein; P I Warkentin; J H Kesey
Journal:  Lancet       Date:  1982-06-05       Impact factor: 79.321

4.  Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours.

Authors:  H F Sears; B Atkinson; J Mattis; C Ernst; D Herlyn; Z Steplewski; P Häyry; H Koprowski
Journal:  Lancet       Date:  1982-04-03       Impact factor: 79.321

5.  Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; S F Schlossman; P H Schur; J A Mills; A D Steinberg
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

6.  Bone marrow transplantation across major histocompatibility barriers in mice. Effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone.

Authors:  D A Vallera; C C Soderling; G J Carlson; J H Kersey
Journal:  Transplantation       Date:  1981-03       Impact factor: 4.939

7.  Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.

Authors:  B Netzel; R J Haas; H Rodt; H J Kolb; S Thierfelder
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

8.  Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells.

Authors:  H E Blythman; P Casellas; O Gros; P Gros; F K Jansen; F Paolucci; B Pau; H Vidal
Journal:  Nature       Date:  1981-03-12       Impact factor: 49.962

Review 9.  Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.

Authors:  J Ritz; S F Schlossman
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

10.  Bone marrow transplantation across major histocompatibility barriers. V. Protection of mice from lethal graft-vs.-host disease by pretreatment of donor cells with monoclonal anti-Thy-1.2 coupled to the toxin ricin.

Authors:  D A Vallera; R J Youle; D M Neville; J H Kersey
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.